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Abstract 
Background: Cancer cells rapidly acquire resistance leading to treatment failures. In the present study, we have 
evaluated the cytotoxicity of 17 methanol extracts from 11 Cameroonian medicinal plants against the sensitive leu-
kemia CCRF–CEM cells and the best ones were further tested on a panel of 8 other human cancer cell lines, including 
various MDR phenotypes as well as against the normal AML12 hepatocytes.
Methods: The cytotoxicity of the extracts was determined using a resazurin reduction assay meanwhile flow 
cytometry was used to measure cell cycle, apoptosis, mitochondrial membrane potential (MMP), and reactive oxygen 
species.
Results: In an initial screening using leukemia CCRF–CEM cells, ten extracts from five plants namely Alchornea 
floribunda, Annona muricata, Euphorbia prostata, Pachypodanthium staudtii and Passiflora edulis displayed IC50 values 
below 20 µg/mL. They were further tested in 8 other cell lines as well as in normal AML12 hepatocytes. All selected 
extracts were active against leukemia CEM/ADR5000 cells with IC50 value below 40 µg/mL. IC50 values ranging from 
10.13 µg/mL (towards CEM/ADR5000 cells) to 72.01 µg/mL [towards resistant colon carcinoma HCT116 (p53−/−) 
cells] for Pachypodanthium staudtii roots and from 0.11 µg/mL (towards CCRF–CEM cells) to 108 µg/mL (towards 
P-glycoprotein-over-expressing CEM/ADR5000 cells) for doxorubicin were obtained in the eight other cancer cell lines 
studied. Extracts from Annona muricata leaves (AML) and seeds (AMS), and Passiflora edulis fruit (PEF) had IC50 values 
below 1 µg/mL against CCRF–CEM cells and below 10 µg/mL against its MDR subline CEM/ADR5000 cells. AML, AMS 
and PEF induced MMP-loss-mediated apoptosis in CCRF–CEM cells.
Conclusions: Results of the present study suggest that some of the tested plants namely Alchornea floribunda, 
Annona muricata, Euphorbia prostata, Pachypodanthium staudtii and Passiflora edulis represent a source of anticancer 
drugs. Annona muricata and Passiflora edulis are good cytotoxic plants that could be exploited to develop phytomedi-
cine to fight mostly hematological cancers including MDR phenotypes.
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Background
The development of resistance to cytotoxic agents rep-
resents a major concern in cancer chemotherapy. Multi-
drug resistance (MDR) is associated with over-expression 
of transmembrane glycoprotein (P-gp) which functions 
as a drug efflux pump, reducing the intracellular levels of 
cytotoxic drugs (Juranka et al. 1989). P-gp belongs to the 
ATP-binding cassette (ABC) transport proteins, which 
also include the multi-drug resistance associated protein 
1 (MRP1) (Shen et  al. 2011; Biedler and Spengler 1994; 
Efferth et al. 2003a), or the breast cancer resistance pro-
tein (BCRP/ABCG2) (Shen et  al. 2011). The oncogene 
epidermal growth factor receptor (EGFR) (Biedler and 
Spengler 1994; Efferth et  al. 2003a, b) and the deletions 
or inactivation of tumor suppressor gene p53 (el-Deiry 
1997) have also been involved in MDR mechanism of 
cancer cells. Overcoming this resistance requires a per-
manent search of new antineoplastic agents. In the past, 
natural products from plant kingdom have revealed a 
high potential as cytotoxic drug reservoir (Kuete and 
Efferth 2011). According to the World Health Organiza-
tion, about 80  % of the population of developing coun-
tries relies on traditional medicines, mostly plant drugs, 
for their primary health care needs (FAO 1997). It has 
also been reported that modern pharmacopoeia still con-
tain at least 25  % drugs derived from plants and many 
others which are synthetic analogues (FAO 1997). There-
fore, fighting cancers with botanicals represents a very 
promising alternative, especially regarding the diversity 
of plant’s secondary metabolites. African flora has pre-
viously been found to be very fruitful in the search of 
antiproliferative molecules. Many compounds including 
xanthones: 8-hydroxycudraxanthone G, morusignin I, 
cudraxanthone I (Kuete et  al. 2013a), and xanthone V1 
(Kuete et  al. 2011a), benzophenones: guttiferone E and 
isogarcinol (Kuete et  al. 2013b), quinone: 2-acetylfuro-
1,4-naphthoquinone (Kuete et  al. 2011a), flavonoids: 
4-hydroxylonchocarpin, 6,8-diprenyleriodictyol (Kuete 
et  al. 2011b), 2′,4′-dihydroxy-3′,6′-dimethoxychalcone 
and 4′-hydroxy-2′,6′-dimethoxychalcone (Kuete et  al. 
2014a; Dzoyem et  al. 2012) and alkaloids: isotetran-
drine (Kuete et al. 2015a) and montrofoline (Kuete et al. 
2015b) displayed good antiproliferative effects against 
various cancer cell lines. In a collaborative research pro-
gramme between the Council for Scientific and Indus-
trial Research (CSIR) in South Africa and the National 
Cancer Institute (NCI) in the USA, several South Afri-
can plant extracts exhibited anticancer activity against 
a panel of three human cell lines (breast MCF7, renal 
TK10 and melanoma UACC62) (Fouche et  al. 2006, 
2008). African medicinal plants such as Fagara heitzii 
(Dzoyem et al. 2013), Echinops giganteus, Xylopia aethi-
opica, Piper capense, Imperata cylindrica (Kuete et  al. 
2011c), Beilschmiedia acuta, Clausena anisata (Kuete 
et  al. 2013c) also displayed good cytotoxicity towards 
drug-sensitive and drug-resistant cancer cell lines. In 
our ongoing search of anticancer products from African 
medicinal flora, we designed the present study to inves-
tigate the cytotoxicity of 11 plants traditionally used to 
manage cancer or disease states bearing relevance to can-
cer or cancer-like symptoms, such as immune and skin 
disorders, inflammatory, infectious, parasitic and viral 
diseases (Kuete et  al. 2015a). The study was extended 
to the evaluation of the ability of the three most active 
extracts from two medicinal plants, Annona muricata 
Lin. (Annonaceae) and Passiflora edulis Sims (Passiflo-
raceae) to alter the cell cycle distribution, caspases activ-
ity, mitochondrial membrane potential (MMP) and to 
increase the production of reactive oxygen species (ROS) 
in leukemia CCRF–CEM cells.
Methods
Plant material and extraction
All medicinal plants tested are traditionally used in the 
management of cancer or disease states with symptoms 
related to cancer. Plants were collected in different regions 
of Cameroon in January 2012. They included Pach-
ypodanthium staudtii, Alchornea floribunda, Annona 
muricata, Canarium schweinfurthii, Hibiscus esculen-
tus, Colocasia esculenta, Moringa oleifera, Triumphetta 
pentandra, Xanthosoma mafaffa, Euphorbia prostata and 
Passiflora edulis. The plant parts investigated are shown 
in Table 1. The plants were identified at the National Her-
barium (Yaoundé, Cameroon), where voucher specimens 
were deposited under the reference numbers shown in 
Table 1. The air-dried and powdered plant material (50 g) 
was soaked in methanol (200 mL) for 48 h, at room tem-
perature. The methanol extract was concentrated in vac-
uum under reduced pressure at 68  °C to give the crude 
extract. This extract was completely dried at room tem-
perature, then conserved at 4 °C until further use.
Chemicals
Doxorubicin 98.0 % and vinblastine ≥96 % from Sigma-
Aldrich (Munich, Germany) were provided by the Uni-
versity Pharmacy of the Johannes Gutenberg University 
(Mainz, Germany), dissolved in phosphate buffer saline 
(PBS; Invitrogen, Eggenstein, Germany) at a concen-
tration of 10  mM and used as positive control drugs. 
Geneticin >98 % (Sigma-Aldrich), stored at a stock con-
centration of 72.18 mM was used to maintain the resist-
ance patterns of MDR carcinoma cell lines.
Cell cultures
The cell lines used in the present study included drug-
sensitive leukemia CCRF–CEM and multidrug-resistant 
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P-glycoprotein-over-expressing subline CEM/ADR5000 
cells (Efferth et al. 2003a; Kimmig et al. 1990; Gillet et al. 
2004), breast cancer MDA-MB-231-pcDNA3 cells and its 
resistant subline MDA-MB-231-BCRP clone 23 (Doyle 
et al. 1998), colon cancer HCT116 (p53+/+) cells and its 
knockout clone HCT116 (p53−/−), glioblastoma U87MG 
cells and its resistant subline U87MG.ΔEGFR (Kuete 
et  al. 2013a, b; Dzoyem et  al. 2013). Leukemia CCRF–
CEM and CEM/ADR5000 cells were maintained in RPMI 
1640 medium (Invitrogen) supplemented with 10 % fetal 
calf serum in a humidified 5 % CO2 atmosphere at 37 °C.
Sensitive and resistant cells were kindly provided by Dr. 
J. Beck (Department of Pediatrics, University of Greif-
swald, Greifswald, Germany). Breast cancer cells trans-
duced with control vector (MDA-MB-231-pcDNA3) or 
with cDNA for the breast cancer resistance protein BCRP 
(MDA-MB-231-BCRP clone 23) were maintained under 
standard conditions as described above for CCRF–CEM 
and CEM/ADR5000 cells. Human wild-type HCT116 
(p53+/+) colon cancer cells as well as knockout clones 
HCT116 (p53−/−) derived by homologous recombina-
tion were a generous gift from Dr. B. Vogelstein and H. 
Hermeking (Howard Hughes Medical Institute, Balti-
more, MD). Human glioblastoma multiforme U87MG 
cells (non-transduced) and U87MG cell line transduced 
with an expression vector harboring an epidermal growth 
factor receptor (EGFR) gene with a genomic deletion of 
exons 2 through 7 (U87MG.ΔEGFR) were kindly pro-
vided by Dr. W. K. Cavenee (Ludwig Institute for Can-
cer Research, San Diego, CA). MDA-MB-231-BCRP, 
U87MG.ΔEGFR and HCT116 (p53−/−) were maintained 
in DMEM medium containing 10 % FBS (Invitrogen) and 
1  % penicillin (100 U/mL)-streptomycin (100  μg/mL) 
(Invitrogen) and were continuously treated with 800 ng/
mL and 400  µg/mL geneticin, respectively. The multid-
rug resistance profile of these cell lines has been reported 
(Doyle et  al. 1998). Human liver hepatocellular carci-
noma HepG2 and the AML 12 normal heptocytes were 
obtained from ATCC (USA). The above medium with-
out geneticin was used to maintained MDA-MB-231, 
U87MG, HCT116 (p53+/+), HepG2 and AML 12 cell 
lines. The cells were passaged twice weekly. All experi-
ments were performed with cells in the logarithmic 
growth phase.
Resazurin reduction assay
The cytotoxicity of the tested samples was performed by 
resazurin reduction assay as previously described (Kuete 
et  al. 2013b; O’Brien et  al. 2000). The assay is based on 
reduction of the indicator dye, resazurin, to the highly 
fluorescent resorufin by viable cells. Non-viable cells 
rapidly lose the metabolic capacity to reduce resazurin 
and thus produced no fluorescent signal. Briefly, adher-
ent cells were detached by treatment with 0.25 % trypsin/
EDTA (Invitrogen) and an aliquot of 1  ×  104 cells was 
placed in each well of a 96-well cell culture plate (Thermo 
Scientific, Germany) in a total volume of 200 µL. Cells 
were allowed to attach overnight and then were treated 
with different concentrations of the studied sample. For 
suspension cells, aliquots of 2 ×  104 cells per well were 
seeded in 96-well-plates in a total volume of 100 µL. The 
studied sample was immediately added in varying con-
centrations in an additional 100 µL of culture medium 
to obtain a total volume of 200 µL/well. After 24 or 48 h, 
20 µL resazurin (Sigma-Aldrich, Germany) 0.01 % w/v in 
ddH2O was added to each well and the plates were incu-
bated at 37  °C for 4  h. Fluorescence was measured on 
an Infinite M2000 Pro™ plate reader (Tecan, Germany) 
using an excitation wavelength of 544 nm and an emis-
sion wavelength of 590  nm. Each assay was done twice, 
with six replicates each. The viability was evaluated based 
on a comparison with untreated cells. IC50 values repre-
senting the sample’s concentrations required to inhibit 
50 % of cell proliferation were calculated from a calibra-
tion curve by linear regression using Microsoft Excel 
(Kuete et al. 2011a; Dzoyem et al. 2012). In a preliminary 
step, all samples were tested against the sensitive CCRF–
CEM cells at various concentrations ranging from 0.16 to 
80 µg/mL (crude extracts) or 0.08 to 10 µg/mL (doxoru-
bicin), and samples displaying IC50 values below 20  µg/
mL were further investigated in 8 other tumor cell lines 
as well as in normal AML12 hepatocytes. Doxorubicin 
was used as positive control, while dimethylsulfoxide 
(DMSO) used to dissolve the samples was used as nega-
tive control. The highest concentration of DMSO was less 
than 0.4 %.
Flow cytometry for cell cycle analysis and detection 
of apoptotic cells
Extracts from Passiflora edulis fruit (PEF), Annona 
muricata leaves (AML), Annona muricata seeds (AMS) 
that displayed the best cytotoxicity as well as doxoru-
bicin were used to treat CCRF–CEM cells (1  ×  106) 
at their IC50 values. Thus, CCRF–CEM cells were cul-
tured in RPMI medium as described above, in the pres-
ence of each sample at a concentration corresponding 
to the IC50 values obtained in the cell line. The cell cycle 
was then analyzed after incubation for 24, 48 and 72  h. 
All reagents, experimental conditions and apparatus 
were identical to those previously reported (Kuete et al. 
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2013a; Dzoyem et  al. 2013). Briefly, cell cycle analysis 
was performed by flow cytometry using Vybrant® Dye-
Cycle™ (Invitrogen, Darmstadt, Germany). Cells were 
measured after Vybrant® DyeCycle™ Violet staining 
(30 min at 37 °C) on a LSR-Fortessa FACS analyzer (Bec-
ton–Dickinson, Heidelberg, Germany) using the violet 
laser. Vybrant® DyeCycle™ Violet stain was measured 
with 440 nm excitation. Cytographs were analyzed using 
FlowJo software (Celeza, Switzerland). All experiments 
were performed at least in triplicate.
Caspase‑Glo 3/7, caspase‑Glo 8 and caspase‑Glo 9 assay
The influence of extracts on caspase 3/7, caspase 8 and 
caspase 9 activity in leukemia CCRF–CEM cell line was 
detected using Caspase-Glo 3/7, Caspase-Glo 8 and 
Caspase-Glo 9 Assay kits (Promega, Germany). Cells cul-
tured in RPMI medium were seeded in 96-well plates and 
treated with the sample (2 ×  IC50; IC50) or DMSO (sol-
vent control). After 6  h incubation in a humidified 5  % 
CO2 atmosphere at 37 °C, 100 µL of caspase reagent were 
added to each well, mixed and incubated for 1 h at room 
temperature. Luminescence was measured using well 
Infinite M2000 Pro™ instrument (Tecan). Caspase activ-
ity was expressed as percentage relative to the untreated 
control (Kuete et al. 2014b).
Analysis of mitochondrial membrane potential (MMP)
The effects of extracts on the MMP were analyzed by 
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazoly
lcarbocyanine iodide) (JC-1; Biomol, Germany) stain-
ing (Kuete et al. 2013c). JC-1 is a dye that can selectively 
enter into mitochondria and exhibits an intense red flu-
orescence in healthy mitochondria with normal mem-
brane potentials. In cells with reduced MMP, the red 
fluorescence disappears. Briefly, 1  ×  106 CCRF–CEM 
cells treated at different concentrations with PEF, AML, 
AMS or vinblastine for 24  h were incubated with JC-1 
staining solution according to the manufacturer`s pro-
tocol for 30  min. Subsequently, cells were measured in 
a LSR-Fortessa FACS analyzer (Becton–Dickinson). For 
each sample, 1 ×  104 cells were counted. The JC-1 sig-
nal was measured with 561 nm excitation (150 mW) and 
detected using a 586/15 nm bandpass filter. The samples 
signal was analyzed with 640 nm excitation (40 mW) and 
detected using a 730/45 nm bandpass filter. All parame-
ters were plotted on a logarithmic scale. Cytographs were 
analyzed using FlowJo software (Celeza, Switzerland). All 
experiments were performed in triplicate.
Measurement of reactive oxygen species (ROS) by flow 
cytometry
The 2′,7′-Dichlorodihydrofluorescein diacetate (H2DCFH-
DA) (Sigma-Aldrich, Germany) is a probe used for the 
highly sensitive and quantifiable detection of ROS. The 
non-fluorescent H2DCFH-DA diffuses into the cells and 
is cleaved by cytoplasmic esterases into 2′,7′-dichlorodi-
hydrofluorescein (H2DCF) which is unable to diffuse back 
out of the cells. In the presence of hydrogen peroxide, 
H2DCF is oxidized to the fluorescent molecule dichloro-
fluorescein (DCF) by peroxidases. The fluorescent signal 
emanating from DCF can be measured and quantified 
by flow cytometry, thus providing an indication of intra-
cellular ROS concentration (Kuete et al. 2011c; Bass et al. 
1983; Cossarizza et al. 2009). Briefly, 2 × 106 CCRF–CEM 
cells were resuspended in PBS and incubated with 2  µM 
H2DCFH-DA for 20  min in the dark. Subsequently, cells 
were washed with PBS and resuspended in RPMI 1640 
culture medium containing different concentrations of 
PEF, AML, AMS or DMSO (solvent control), or hydrogen 
peroxide (H2O2; positive control). After 24 h of incubation, 
cells were washed and suspended in PBS. Subsequently 
cells were measured in a FACSCalibur flow cytometer 
(Becton–Dickinson, Germany). For each sample 1 ×  104 
cells were counted. DCF was measured at 488 nm excita-
tion (25mW) and detected using a 530/30  nm bandpass 
filter. All parameters were plotted on a logarithmic scale. 
Cytographs were analyzed using FlowJo software (Celeza, 
Switzerland). All experiments were performed in triplicate.
Results
Cytotoxicity of the studied samples
In this study, we first screened the cytotoxicity of 17 
crude extracts belonging to 11 plants towards drug-sensi-
tive CCRF–CEM leukemia cells. The results are shown in 
Table 2. All tested extracts had IC50 values below 80 µg/
mL. Ten extracts from five plants including Alchornea 
floribunda bark (AFB), Annona muricata fruit peri-
carp (AMP), leaves (AML) and seeds (AMS), Euphorbia 
prostata whole plant (EPW), Pachypodanthium staudtii 
bark (PSB), leaves (PSL) and roots (PSR), and Passiflora 
edulis fruit pericarp (PEP) and fruit (PEF) displayed IC50 
values below 20  µg/mL in CCRF–CEM cells (Table  2). 
These extracts were further selected for IC50 determina-
tion towards a panel of sensitive and MDR cell lines. The 
results summarized in Table  3 indicate that all selected 
extracts were also active against P-glycoprotein-over-
expressing CEM/ADR5000 leukemia cells with IC50 val-
ues below 40 µg/mL. IC50 values ranged from 10.13 µg/
mL (towards CEM/ADR5000 cells) to 72.01  µg/mL (on 
resistant colon carcinoma HCT116 (p53−/−) cells) for 
PSR, from 14.97  µg/mL (on CEM/ADR5000 cells) to 
65.68  µg/mL (against HCT116 (p53−/−) cells) for PSB, 
from 18.21  µg/mL (against CEM/ADR5000 cells) to 
65.21 µg/mL (on HCT116 (p5+/+) cells) for PSL and from 
0.11  µg/mL (towards CCRF–CEM cells) to 108  µg/mL 
(against CEM/ADR5000 cells) for doxorubicin in the 8 
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other cancer cell lines studied. Apart from extract from 
P. staudtii, other extracts were less active on carcinoma 
cells including normal AML12 hepatocytes, with IC50 
values above 80  µg/mL. Collateral sensitivity (or hyper-
sensitivity: higher toxicity to resistant than to sensitive 
cells with a degree of resistance below 1) (Kuete et  al. 
2013a) was observed in CEM/ADR5000 cells to PSB 
(degree of resistance of 0.87-fold) and PSR (0.59-fold) 
(Table  3). Hypersensitivity of resistant carcinoma cells 
was also recorded in many cases to PSL, PSB or PSR even 
though they were moderately active. However, if cross-
resistance of CEM/ADR5000 cells to the tested extracts 
were observed, the degrees of resistance were in all cases 
lower than that of doxorubicin (Table 3). AMS, AML and 
PEF had IC50 values below 1 and 10  µg/mL in sensitive 
CCRF/CEM cells and it resistant subline CEM/ADR5000 
cells respectively; they were subsequently selected for 
mechanistic studies. 
Cell cycle distribution and apoptosis
The best extracts (AMS, AML and PEF) as well as doxo-
rubicin were used to treat CCRF–CEM cells at their IC50 
values, and the cycle distribution was analyzed. Results 
depicted in Fig.  1 show dose-dependent and significant 
modifications of the cell cycle phases after treatment 
of cells with all samples. Both PEF and AML induced 
cell cycle arrest in G0/G1 phase while AMS induced 
cell cycle arrest in S-phase. After treatment with these 
three extracts, CCRF–CEM cells underwent apopto-
sis with dose-dependent increases in sub-G0/G1 phase. 
The percentages of cells in sub-G0/G1 phase varied from 
9.31 % (in 24 h) to 48.69 % (72 h), from 8.87 % (in 24 h) to 
33.98 % (72 h) and from 11.03 % (24 h) to 21.63 % (72 h) 
after PEP, AML and AMS treatments respectively, while 
doxorubicin increased apoptosis in a range of 6.02  % 
(24 h) to 51.87 % (72 h). The highest percentage of sub-
G0/G1 phase in non-treated cells was only 6.42  % after 
72 h.
Effects on the activity of caspases, MMP and ROS
After treating CCRF–CEM cells for 6 h at different con-
centrations of PEF, AML and AMS, no changes of caspase 
3/7, caspase 8 and caspase 9 activities were observed. 
No increase in ROS production was also not found in 
CCRF–CEM cells treated with the three extracts (data 
not shown). PEF, AML and AMS induced significant 
MMP loss in the respective ranges of 35.3  % (1/2-fold 
IC50 treatment) to 46.7  % (2-fold IC50), 28.2  % (1/2-fold 
IC50) to 53.8  % (2-fold IC50) and 36.6  % (1/2-fold IC50) 
to 51.0 % (2-fold IC50) (Fig. 2). A 48.6 % loss of MMP at 
2-fold IC50 of vinblastine was previously reported under 
similar experimental conditions in CCRF–CEM cells 
(Kuete et al. 2013a).
Discussion
According to the U.S. National Cancer Institute (NCI) 
plant screening program, plant extracts with IC50 val-
ues below of 20 µg/mL following incubation between 48 
and 72  h (Boik 2001) are recognized as potential cyto-
toxic substances. In the present study, multi-factorial 
drug-resistant cancer cell lines such as leukemia CEM/
ADR5000 cells over-expressing P-gp, breast adenocarci-
noma MDA-MB-231-BCRP clone 23 expressing BCRP, 
EGFR-transfected U87MG.ΔEGFR glioblastoma cells 
and p53 knockout HCT116 (p53−/−) colon cancer cells 
(Efferth et al. 2003a; Kuete et al. 2013a, b, 2014c; Kimmig 
et al. 1990; Gillet et al. 2004; Doyle et al. 1998) were used 
to determine the cytotoxicity the selected plant extracts. 
In the first step of the investigations, we carried out a 
preliminary assays with the sensitive leukemia CCRF–
CEM cells. In regards to the NCI threshold, AFB, AMP, 
AML, AMS, EPW, PSB, PSL, PSR, PEP and PEF (Table 2) 
displaying IC50 values below 20 µg/mL were selected and 
Table 2 IC50 values of the tested plant extracts towards leu-
kemia CCRF–CEM cells and as determined by the resazurin 
assay
In italics: significant cytotoxic effect
Tested plant and parts IC50 values (µg/mL)
Plants Parts
Alchornea floribunda Bark (AFB) 18.88 ± 1.65
Leaves 46.00 ± 4.26
Annona muricata Fruit pericarp (AMP) 4.58 ± 0.25
Leaves (AML) 0.57 ± 0.02
Seeds (AMS) 0.36 ± 0.03
Canarium schweinfurthii Fruit 38.62 ± 3.69
Colocasia esculenta Leaves 38.19 ± 4.39
Euphorbia prostata Whole plant (EPW) 18.59 ± 1.12
Hibiscus esculentus Fruit 60.79 ± 7.04
Moringa oleifera Leaves 29.79 ± 1.26
Pachypodanthium staudtii Bark (PSB) 17.22 ± 1.16
Leaves (PSL) 13.59 ± 1.12
Roots (PSR) 17.62 ± 1.18
Passiflora edulis Fruit pericarp (PEP) 3.41 ± 0.55
Fruit (PEF) 0.69 ± 0.13
Triumphetta pentandra Leaves 36.28 ± 2.84
Xanthosoma mafaffa Leaves 43.20 ± 0.99
Doxorubicin 0.11 ± 0.03
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further tested on a panel of 8 other cell lines. Interest-
ingly, the P-gp over-expressing leukemia CEM/ADR5000 
was also sensitive to most of the extracts with IC50 value 
below 20  µg/mL obtained with AML, AMS, PSL, PSB, 
PSR, PEF and PEP. This suggests that these extracts can 
be used to manage hematological cancers including 
resistant phenotypes. Data obtained with AML, AMS 
and PEP are very interesting as they displayed IC50 val-
ues below 10  µg/mL in the resistant CEM/ADR5000 
cells and even below 1 µg/mL in its sensitive counterpart 
CCRF–CEM cells. Nonetheless, they were not active in 
carcinoma cells, clearly indicating their selectivity to leu-
kemia cells. Alteration of MMP has been reported as a 
mode of apoptosis induction of plant extracts (Kuete and 
Efferth 2015). AML, AMS and PEP induced MMP loss 
but no caspase activation nor increase ROS production. 
Hence, MMP is the main mode of induction of apoptosis 
of AML, AMS and PEP in CCRF–CEM cells as observed 
in this study.
To the best of our knowledge, the cytotoxicty of the five 
most active plants, Alchornea floribunda, Annona muri-
cata, Euphorbia prostata, Pachypodanthium staudtii 
and Passiflora edulis towards the cell line panel tested in 
this study is being reported for the first time. Neverthe-
less, the leaves ethanol extract of Annona muricata was 
reported to have antiproliferative effect against leuke-
mia HL-60 cells with an IC50 value of 14 µg/mL, and also 
induced apoptosis through the loss of MMP with G0/G1 
phase cell arrest (Pieme et al. 2014). This is in accordance 
with data reported herein. The ethyl acetate extract of 
the leaves of this plant harvested in Malaysia was also 
found active against colon carcinoma HCT-116 and 
HT-29 cells with the respective IC50 values of 11.43 and 
8.98 µg/mL (Zorofchian Moghadamtousi et al. 2014). In 
the present study, IC50 were not detected at up to 80 µg/
mL, either indicating that the active constituents of the 
plant against carcinoma cells might not be well extracted 
with methanol or that the geographic distribution influ-
ences the cytotoxic potential of the plant. Also the meth-
anol extracts of the leaves and fruits of Passiflora edulis 
harvested in Egypt were screened at 100  µg/mL against 
HCT-116 cells, HepG2 cells as well as against the breast 
carcinoma MCF-7 cells and lung carcinoma A-549 cells; 
As results, less than 50 % growth inhibition was recorded 
(Moustafa et  al. 2014), coroborating the low activity 
obtained with various parts of this plant against carci-
noma cells.
Conclusions
In this study, ten extracts from five medicinal plants, 
Alchornea floribunda, Annona muricata, Euphorbia 
prostata, Pachypodanthium staudtii and Passiflora edu-
lis had good cytotoxicity against CCRF–CEM leukemia 
cells and its resistant subline CEM/ADR5000 cells. Their 
selectivity to these two cell lines, indicates that they can 
be sources for the development of novel anticancer drugs 
to fight leukemia. AML, AML and PEF were the most 
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Fig. 1 Cell cycle distribution of CCRF–CEM leukemia cells treated with extracts from PEF, AML and AMS or doxorubicin. PEF, AML and AMS were 
tested at 0.69, 0.57 and 0.36 and 8.02 µg/mL respectively while doxorubicin was tested at 0.11 µg/mL corresponding to their IC50
Page 10 of 12Kuete et al. SpringerPlus  (2016) 5:1666 
Fig. 2 Effect of PEF, AML and AMS on the mitochondrial membrane potential in CCRF–CEM cells. C control; PEF was tested at 24 h at 0.35 µg/mL 
(PEF1), 0.69 µg/mL (PEF2), and 1.38 µg/L (PEF3) while AML was tested at 0.29 µg/mL (AML1), 0.57 µg/mL (AML2), and 1.14 µg/mL (AML3) and AMS 
was tested at 0.18 µg/mL (AML1), 0.36 µg/mL (AML2), and 0.72 µg/mL (AML3) corresponding to 1/2-fold, IC50 and 2-fold IC50. Data for the positive 
control, vinblastine in similar experimental conditions were previously reported (Kuete et al. 2013b); Loss of MMP (Q1), intact cells (Q2), ruptured cell 
membrane (Q3 and Q4)
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cells mediated by loss of MMP. Further phytochemical 
investigations of these extracts will be done to isolate 
their active constituents.
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